Original Research
Published on 27 Jul 2023
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma
in Genitourinary Oncology
- 3,664 views
- 4 citations
Original Research
Published on 27 Jul 2023
in Genitourinary Oncology
Case Report
Published on 26 Jul 2023
in Genitourinary Oncology
Case Report
Published on 26 Jul 2023
in Genitourinary Oncology
Mini Review
Published on 21 Jul 2023
in Genitourinary Oncology
Systematic Review
Published on 20 Jul 2023
in Genitourinary Oncology
Systematic Review
Published on 19 Jul 2023
in Genitourinary Oncology
Case Report
Published on 14 Jul 2023
in Genitourinary Oncology
Systematic Review
Published on 13 Jul 2023
in Genitourinary Oncology
Original Research
Published on 13 Jul 2023
in Genitourinary Oncology
Editorial
Published on 10 Jul 2023
in Genitourinary Oncology
Original Research
Published on 06 Jul 2023
in Genitourinary Oncology
Review
Published on 06 Jul 2023
in Genitourinary Oncology
Original Research
Published on 05 Jul 2023
in Genitourinary Oncology
Editorial
Published on 04 Jul 2023
in Genitourinary Oncology
Original Research
Published on 30 Jun 2023
in Genitourinary Oncology
Review
Published on 30 Jun 2023
in Genitourinary Oncology
Original Research
Published on 29 Jun 2023
in Genitourinary Oncology
Original Research
Published on 28 Jun 2023
in Genitourinary Oncology
Original Research
Published on 28 Jun 2023
in Genitourinary Oncology
Case Report
Published on 27 Jun 2023
in Genitourinary Oncology
Original Research
Published on 27 Jun 2023
in Genitourinary Oncology
Case Report
Published on 26 Jun 2023
in Genitourinary Oncology
Review
Published on 26 Jun 2023
in Genitourinary Oncology
Review
Published on 26 Jun 2023
in Genitourinary Oncology